Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Portable Monitoring System Tracks Real-Time Brain Activity

By LabMedica International staff writers
Posted on 07 Feb 2016
Print article
Image: The Cognionics wearable 72-channel EEG headset (Photo courtesy of Cognionics).
Image: The Cognionics wearable 72-channel EEG headset (Photo courtesy of Cognionics).
An innovative wearable brain activity monitoring system with dry electroencephalogram (EEG) sensors provides a better solution for real-world applications.

Developed by researchers at the University of California, San Diego (UCSD, USA), the HD-72 headset features a wearable 72-channel (64 EEG + 8 ExG) form factor, compact electronics with active shielding, and a wireless triggering system. Active dry-contact electrodes leverage a pressure-induced flexing mechanism to contact the scalp through hair. A sophisticated software suite wirelessly streams data for online analysis, including adaptive artifact rejection, cortical source localization, multivariate effective connectivity inference, data visualization, and cognitive state classification.

The octopus-like headset has 18 tentacles, in which each arm is elastic, so that it can fit different head shapes. The sensors at the end of each arm are designed to make optimal contact with the scalp while adding as little noise in the signal as possible. The sensors are are made of a mix of silver and carbon deposited on a flexible substrate with a silver/silver-chloride coating. This allows them to remain flexible and durable while still conducting high-quality signals. The data captured is first separated from high amplitude artifacts generated when subjects move, speak, or even blink.

This is achieved by an algorithm that separates the EEG data into different components statistically unrelated to one another. It then compares these elements with clean data obtained, for instance, when a subject is at rest; abnormal data is labeled as noise and discarded. The data collected is also tracked to see how signals from different areas of the brain interact with one another, creating an ever-changing network map of brain activity. Machine learning then connects specific network patterns in brain activity to cognition and behavior. The study describing the system was published in the November 2015 issue of IEEE Transactions on Biomedical Engineering.

“This is going to take neuroimaging to the next level by deploying on a much larger scale. You will be able to work in subjects’ homes; you can put this on someone driving,” said study coauthor Mike Yu Chi, MSc and CTO of Cognionics (San Diego, CA, USA), which is developing the system commercially.

Related Links:

University of California, San Diego
Cognionics


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Immunofluorescence Analyzer
MPQuanti
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.